Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease
A. Wyttenbach et al., Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease, HUM MOL GEN, 10(17), 2001, pp. 1829-1845
Huntington's disease (HD) is one of 10 known diseases caused by a (CAG)(n)
trinucleotide repeat expansion that is translated into an abnormally long p
olyglutamine tract. We have developed stable inducible neuronal (PC12) cell
lines that express huntingtin exon 1 with varying CAG repeat lengths under
doxycycline (dox) control. The expression of expanded repeats is associate
d with aggregate formation, caspase-dependent cell death and decreased neur
ite outgrowth. Post-mitotic cells expressing mutant alleles were more prone
to cell death compared with identical cycling cells. To determine early me
tabolic changes induced by this mutation in cell models, we studied changes
in gene expression after 18 h dox induction, using Affymetrix arrays, cDNA
filters and adapter-tagged competitive PCR (ATAC-PCR). At this time point
there were low rates of inclusion formation, no evidence of mitochondrial c
ompromise and no excess cell death in the lines expressing expanded compare
d with wildtype repeats. The expression profiles suggest novel targets for
the HD mutation and were compatible with impaired cAMP response element (CR
E)-mediated transcription, which we confirmed using CRE-luciferase reporter
assays. Reduced CRE-mediated transcription may contribute to the loss of n
eurite outgrowth and cell death in polyglutamine diseases, as these phenoty
pes were partially rescued by treating cells with cAMP or forskolin.